Actinic cheilitis is a common precancerous lesion of the lip. The purpose of this study is to compare imiquimod 5% therapy and photodynamic therapy. The data will include effect data, histology (skin analysis), epidemiological data and follow-up data.
Randomized study comparing imiquimod 5% with photodynamic therapy for actinic cheilitis. Histological, efficacy, epidemiological and clinical data will be collected.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
53
Imiquimod 5% cream used three days a week for 4 weeks
Photodynamic therapy involves applying Metvix cream to the affected area followed by illumination. It will be done twice during the study at a 2 week interval.
St. Olavs Hospital
Trondheim, Norway
clinical and pathological complete cure rates.
Time frame: 3 and 12 months after therapy
clinical, safety, epidemiological and histopathological data
Through collecting patient data and post-treatment biopsy
Time frame: post-treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.